Figure 2.
Recommended MRD technology by ELN risk and genetic subgroup for pre-alloHCT and post-alloHCT MRD monitoring. bZIP inframe, inframe mutations in the bZIP domain; mut, mutated; wt, wild type.

Recommended MRD technology by ELN risk and genetic subgroup for pre-alloHCT and post-alloHCT MRD monitoring. bZIP inframe, inframe mutations in the bZIP domain; mut, mutated; wt, wild type.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal